IDEXX Laboratories Inc
IDXX- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000874716
In the last 90 days, IDEXX Laboratories Inc insiders filed 0 open-market purchases and 1 sale; 1,306 institutions reported holding it in 13F filings for Q2 2026, worth $39.1B in total; 3 superinvestors hold it, including Fundsmith and Weitz Investment Management.
Q3 2021 vs. Q2 2021
How the institutions holding IDEXX Laboratories Inc changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 1,037 | 12 | 1,063 | +38 |
| Shares | 73.0M | 254.1K | 71.6M | −1.14M (−1.6%) |
| Value | $46.1B | $160.5M | $44.6B | −$1.36B (−3.0%) |
12 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (104)
Institutions that held IDEXX Laboratories Inc at the end of Q3 2021 but not at the end of Q2 2021.
Showing the largest 100 of 104 by value.
Sold out (66)
Institutions that held IDEXX Laboratories Inc at the end of Q2 2021 and filed for Q3 2021 without it.
Not filed for Q3 2021 yet (12)
Institutions that held IDEXX Laboratories Inc at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Pictet Asset Management Ltd | 230,371 | $145.5M |
| QS Investors, LLC | 13,680 | $8.64M |
| Western Wealth Management, LLC | 5,005 | $3.16M |
| CWM, LLC | 2,557 | $1.61M |
| Usca Ria LLC | 1,133 | $716.0K |
| Triune Financial Partners, LLC | 628 | $396.8K |
| Financial Consulate Inc. | 326 | $206.0K |
| First Horizon Corp | 138 | $87.0K |
| Castleview Partners, LLC | 118 | $75.0K |
| PNC Managed Account Solutions, Inc. | 85 | $54.0K |
| Hoover Financial Advisors, Inc. | 60 | $38.0K |
| FormulaFolio Investments, LLC | 28 | $18.0K |